Report Id: PPMM0621
Personalized Medicine Market Size by Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The Personalized Medicine Market is expected to be around US$ 765.69 Billion by 2028 at a CAGR of 6.57% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Illumina Inc
- ASURAGEN INC
- GE Healthcare
- Danaher Corporation
- Abbott
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
6
REPORT DESCRIPTION
The Personalized Medicine Market is expected to be around US$ 765.69 Billion by 2028 at a CAGR of 6.57% in the given forecast period.
Personalized medicine can be defined as a type of treatment which concentrations on the individual physiognomies of each patient. Personalized medicine possesses a huge prospective in leading the healthcare industry with strong alterations and modifications with prime emphasis on the understanding & management of diseases combined with patient data, tailored medicines, advanced analytics, and other possibilities. Advancements in science and technology are changing, especially the way personalized medicine describe the disease, develop drugs, and recommend treatments. The concept of personalized medicine has emerged with increasing advances in genomic and proteomic science over the past decade which has given a boost to the development of therapeutics and targeted diagnostics that effect knowledge of an individual’s genetic makeup to construct a more personalized approach to healthcare. The rising dominance of many types of cancer, affordability of personalized medicine therapy in cancer drugs and several other disease indications are expected to fuel the market for Personalized Medicine in the global market.
The global Personalized Medicine market is segregated on the basis of Product as Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, and Personalized Nutrition & Wellness.
The global Personalized Medicine market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Personalized Medicine market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Illumina, Inc., GE Healthcare, Danaher Corporation, Abbott, QIAGEN, Exact Sciences Corporation, ASURAGEN, INC., Biogen, Dako A/S, Exagen Inc., Precision Biologics, Celera Diagnostics LLC, Decode Genetics, Inc., Genelex, IBM, and others are among the major players in the global Personalized Medicine market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Personalized Medicine Market has been segmented as below:
Personalized Medicine Market, By Product
- Personalized Medicine Diagnostics
- Genetic Testing
- DTC Diagnostics
- Esoteric Lab Services
- Esoteric Lab Tests
- Personalized Medicine Therapeutics
- Pharmaceutical
- Genomic Medicine
- Medical Devices
- Personalized Medical Care
- Telemedicine
- Health Information Technology
- Personalized Nutrition & Wellness
- Retail Nutrition
- Complementary & Alternative Medicine
Personalized Medicine Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Personalized Medicine Market, By Company
- Illumina, Inc.
- GE Healthcare
- Danaher Corporation
- Abbott
- QIAGEN
- Exact Sciences Corporation
- ASURAGEN, INC.
- Biogen
- Dako A/S
- Exagen Inc.
- Precision Biologics
- Celera Diagnostics LLC
- Decode Genetics, Inc.
- Genelex
- IBM
The report covers:
- Global Personalized Medicine market sizes from 2021 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2023 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global Personalized Medicine market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Personalized Medicine market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global Personalized Medicine market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Personalized Medicine market share. Major industry players with significant revenue share include Illumina, Inc., GE Healthcare, Danaher Corporation, Abbott, QIAGEN, Exact Sciences Corporation, ASURAGEN, INC., Biogen, Dako A/S, Exagen Inc., Precision Biologics, Celera Diagnostics LLC, Decode Genetics, Inc., Genelex, IBM, and others.
Reasons to Buy this Report:
- Gain detailed insights on the Personalized Medicine industry trends
- Find complete analysis on the market status
- Identify the Personalized Medicine market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Drug of Abuse (DOA) Testing Equipment Market
Latin America excipients market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Personalized Medicine Market, By Type
5.1. Key Points
5.2. Orange oil
5.3. Lemon oil
5.4. Lime oil
5.5. Peppermint oil
5.6. Cornmint oil
5.7. Citronella oil
5.8. Spearmint oil
5.9. Geranium oil
5.10. Clove leaf oil
5.11. Eucalyptus oil
5.12. Jasmine oil
5.13. Tea tree oil
5.14. Rosemary oil
5.15. Lavender oil
5.16. Other
6. Personalized Medicine Market, By Method of Extraction
6.1. Key Points
6.2. Distillation
6.3. Carbon dioxide extraction
6.4. Cold press extraction
6.5. Solvent extraction
6.6. Other extraction methods
7. Personalized Medicine Market, By Application
7.1. Key Points
7.2. Personalized Medicine Diagnostics
7.2.1. Genetic Testing
7.2.2. DTC Diagnostics
7.2.3. Esoteric Lab Services
7.2.4. Esoteric Lab Tests
7.3. Personalized Medicine Therapeutics
7.3.1. Pharmaceutical
7.3.2. Genomic Medicine
7.3.3. Medical Devices
7.4. Personalized Medical Care
7.4.1. Telemedicine
7.4.2. Health Information Technology
7.5. Personalized Nutrition & Wellness
7.5.1. Retail Nutrition
7.5.2. Complementary & Alternative Medicine
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers & Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profiles
9.1 IBM
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Genelex
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Decode Genetics, Inc.
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Celera Diagnostics LLC
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Precision Biologics
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Exagen Inc.
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Dako A/S
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Biogen
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 ASURAGEN, INC.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Exact Sciences Corporation
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
9.11 QIAGEN
9.11.1 Company Overview
9.11.2 Product/Service Landscape
9.11.3 Financial Overview
9.11.4 Recent Developments
9.12 Abbott
11.12.1 Company Overview
9.12.2 Product/Service Landscape
9.12.3 Financial Overview
9.12.4 Recent Developments
9.13 Danaher Corporation
9.13.1 Company Overview
9.13.2 Product/Service Landscape
9.13.3 Financial Overview
9.13.4 Recent Developments
9.14 GE Healthcare
9.14.1 Company Overview
9.14.2 Product/Service Landscape
9.14.3 Financial Overview
9.14.4 Recent Developments
9.15 Illumina, Inc.
9.15.1 Company Overview
9.15.2 Product/Service Landscape
9.15.3 Financial Overview
9.15.4 Recent Developments
The Personalized Medicine Market has been segmented as below:
Personalized Medicine Market, By Product
- Personalized Medicine Diagnostics
- Genetic Testing
- DTC Diagnostics
- Esoteric Lab Services
- Esoteric Lab Tests
- Personalized Medicine Therapeutics
- Pharmaceutical
- Genomic Medicine
- Medical Devices
- Personalized Medical Care
- Telemedicine
- Health Information Technology
- Personalized Nutrition & Wellness
- Retail Nutrition
- Complementary & Alternative Medicine
Personalized Medicine Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Personalized Medicine Market, By Company
- Illumina, Inc.
- GE Healthcare
- Danaher Corporation
- Abbott
- QIAGEN
- Exact Sciences Corporation
- ASURAGEN, INC.
- Biogen
- Dako A/S
- Exagen Inc.
- Precision Biologics
- Celera Diagnostics LLC
- Decode Genetics, Inc.
- Genelex
- IBM
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Personalized Medicine Market?
The market is expected to grow at a CAGR of 6.57% during the study period (2023-2028)
How big is the Personalized Medicine Market value?
The Personalized Medicine Market is expected to be around US$ 765.69 Billion by 2028
What is the segment’s covered for the Personalized Medicine Market?
The segment included in Personalized Medicine Market is Product and region.
Who are the major key vendors in the Personalized Medicine Market?
Some key players operating in the Personalized Medicine Market include Illumina, Inc., GE Healthcare, Danaher Corporation, Abbott, QIAGEN, Exact Sciences Corporation, ASURAGEN, INC., Biogen, Dako A/S, Exagen Inc., Precision Biologics, Celera Diagnostics LLC
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE